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Volume 49, Number 5S Plenary Sessions 11Sscores were 89.1 and 89.5. On average, an integrated applicant had pub-
lished 2.8 peer-reviewed publications.
Conclusion: The number of talented and motivated integrated appli-
cants far outweighs the number of available positions. Growing interest in
more efficient and comprehensive training will continue to augment de-
mand. As educators, vascular surgeons should seize this opportunity and
aggressively expand the number of available positions.
Author Disclosures: A. Schanzer,None; J. Nahmias,None;K. Korenda,
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The Role Of Robotic Endovascular Catheters In Fenestrated Stent
Grafting
Celia V Riga, Colin D Bicknell, Mohamad S Hamady, Nicholas J Cheshire.
St Mary’s Hospital, Imperial College Healthcare NHS Trust, London,
United Kingdom
Backround: Advances in stent graft technology have allowed the
treatment of complex thoraco-abdominal aneurysm disease via a total endo-
vascular approach but the procedure can be technically challenging and time
consuming.
Methods: A 4-vessel fenestrated stent graft partially deployed within a
CT-reconstructed pulsatile Type-II thoraco-abdominal aneurysm silicon
model was used. Twelve vascular specialists were asked to cannulate the renal
and visceral vessels under fluoroscopic guidance, using conventional and
robotic techniques. Quantitative (catheterization times and wire/catheter
tip movements) and qualitative metrics (validated procedure-specific-rating
scale (IC3ST), which grades operators on catheter use, instrumentation,
successful cannulation/catheterisation and overall performance assessed by
two blinded observers (Cronbach’s 0.94)) were compared (Wilcoxon
signed-rank test).
Results: Median procedure times for cannulation of all 4 vessels were
reduced using robotic catheters (2.9min IQR(2.3-4.2) versus 14min(11.1-
19.6); p0.002). The total number of wire/catheter movements taken to
complete the task was also significantly reduced (38 IQR(27.3-64.8) versus
423(221-662); p0.002). There were significant differences in time and
movement for cannulation of each individual vessel in the phantom. Roboticcatheter operator radiation exposure was minimal. Procedure-specific per-
formance scores were significantly improved with robotic catheterization
despite minimal operator exposure (IC3ST score 29/35 IQR(21.8-30.6)
versus 18.8/35 (11.5-24.1); p0.006).
Conclusions: Robotic catheterisation of target vessels during this
procedure is feasible and minimises radiation exposure for the operator.
Steerable robotic catheters with intuitive control may overcome some of the
limitations of standard catheter technology, enhance target vessel cannula-
tion, reduce instrumentation and improve overall performance scores.
Author Disclosures: C.V. Riga, None; C.D. Bicknell, None; M.S.
Hamady, None; N.J. Cheshire, None.
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Protamine Reduces Bleeding Complications Associated With Carotid
Endarterectomy Without Increasing the Risk of Stroke
David H. Stone1, Brian W. Nolan1, Andres Schanzer2, Philip P Goodney1,
Robert A. Cambria3, Donald S. Likosky1, Daniel B.Walsh1, Jack L. Cronen-
wett1, for the Vascular Study Group of NorthernNew England (VSGNNE).
1Dartmouth Hitchcock Medical Center, Lebanon, NH; 2University of
Massachusetts Medical School, Worcester, MA; 3Eastern Maine Medical
Center, Bangor, ME
Objectives: Controversy exists about whether protamine given during
carotid endarterectomy (CEA) prevents bleeding or increases thrombotic
complications such as stroke or myocardial infarction (MI). The purpose of
this study was to determine the effect of protamine reversal of heparin
anticoagulation on the outcome of CEA.
Methods: A prospective regional registry in Northern New England of
4,712 patients undergoing CEA by 66 surgeons from 11 centers from
2003-2008, was reviewed. Protamine use varied by surgeon (38% routine
use, 44% rare use, 18% variable use). The primary endpoint was postopera-
tive bleeding requiring reoperation. Secondary endpoints included stroke,
death and MI. Predictors of endpoints were determined by univariate
analysis using Pearson chi-square (Fisher’s exact correction) andmultivariate
logistic regression.
Results: Among 4712 patients undergoing CEA, 46% received prota-
mine while 54% did not. Patients who did not receive protamine had a
2.6-fold increase in reoperation for bleeding (Table). Protamine use did not
affect the rate of stroke, death, or MI. By multivariate analysis, protamine
reduced bleeding complications after accounting for other potential predic-
tors of bleeding including center variation, surgical technique, and antiplate-
let therapy; (OR 0.43, 95% CI 0.18-0.98, P.05). Consequences of reop-
eration for bleeding were a 7-fold increase in stroke, a 30-fold increase in
death and a 4-fold increase in MI.
Conclusion: Protamine reduces serious bleeding complications during
CEA without increasing the risk of stroke, death, or MI. Thus, protamine is
both safe and beneficial during CEA as practiced in this large, prospective
registry. In light of substantial complications referable to bleeding, liberal
use of protamine during CEA appears warranted.
N
Reoperation
For bleeding Stroke Death MI
Protamine 2180 14 (0.64%) 17 (0.78%) 5 (0.23%) 24 (1.1%)
No Protamine 2532 42 (1.66%) 29 (1.15%) 8 (0.32%) 23 (0.91%)
Chi-square P0.001 P0.20 P0.57 P0.51
Author Disclosures: D.H. Stone, None; B.W. Nolan, None; A. Schan-
zer, None; P.P. Goodney, None; R.A. Cambria, None; D.S. Likosky,
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SS32.
Carotid Endarterectomy In Female Patients: Subsets Of Patients At
Higher Surgical Risk
Walter Dorigo1, JohnMarek2, Raffaele Pulli1, Alessandro Alessi Innocenti1,
Giovanni Pratesi3, Carlo Pratesi1. 1University of Florence, florence, Italy;
2University of NewMexico, Albuquerque, NM; 3University of Tor Vergata,
Rome, ItalyObjectives:To evaluate early and late results of carotid endarterectomy
(CEA) in female patients in a large single center experience.
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consecutive CEAs were performed at our institution. All patients were
prospectively enrolled in a dedicated database containing pre, intra and
postoperative parameters. Patients were female in 1200 cases (Group 1) and
male in the remaining 2809 (Group 2). Early results in terms of intraoper-
ative neurological events and 30-day stroke and death rates were analyzed
and compared. Follow-up results were analyzed with Kaplan Meyer curves
and compared with log-rank test.
Results: Patients of group 1 were more likely to have hyperlipemia,
diabetes and hypertension; patients of group 2 were more likely to be
smokers and to have concomitant coronary artery disease (CAD) and
peripheral arterial disease (PAD). There were no differences in terms of
clinical status or degree of stenosis. Patients of group 2 had a significantly
higher percentage of contralateral carotid artery occlusion than patients in
group 1 (6.9% and 3.9%, respectively). There were no-differences in terms of
intraoperative neurological events (0.4% and 0.9%, respectively); and 30-day
stroke and death rates were similar in the two groups (1.2% for both groups).
Univariate analysis demonstrated the presence of CAD, PAD, diabetes and
contralateral carotid artery occlusion to significantly affect 30-day stroke and
death rate in female patients. At multivariate analysis, only diabetes (OR 3.6,
95%CI 0.1-0.9) and contralateral occlusion (OR 7.4, 95%CI 0.03-05) were
independently associated with an increased periperative risk of stroke and
death. Median duration of follow-up was 27 months (range 1-144). There
were no differences between the two groups in terms of survival, freedom
from ipsilateral stroke, freedom from any neurological symptom and free-
dom from severe (70%) restenosis.
Conclusions: Female sex per se does not represent an adjunctive risk
factor during CEA, with early and long term results comparable to those
obtained in male patients. However, there are several subgroups of female
patients at higher surgical risk, requiring appropriate selection and careful
intra and postoperative management.
Author Disclosures: W. Dorigo, None; J. Marek, None; R. Pulli, None;
A. Alessi Innocenti, None; G. Pratesi, None; C. Pratesi, None.
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SVS Vascular Registry for Carotid Procedures: Comparison of CAS
Outcomes for Atherosclerotic Carotid Artery Disease with Non-ath-
erosclerotic Carotid Artery Disease
Rodney A. White1, Gregorio A. Sicard2, Robert M Zwolak3, Anton N
Sidawy4, Marc L Schermerhorn5, Flora S Siami6, SVS Outcomes Commit-
tee. 1Harbor UCLA Medical Center, Torrance, CA; 2Washington Univer-
sity School of Medicine, St. Louis, MO; 3Dartmouth-Hitchcock Medical
Center, Lebanon, NH; 4Washington VAMedical Center, Washington, DC;
5Beth Israel Deaconess Medical Center, Boston, MA; 6New England Re-
search Institutes, Inc., Watertown, MA
Objective: The Vascular Registry (VR) collects long-term outcomes
on CAS and CEA patients. The purpose of this report is to describe
peri-operative and 30-day CAS outcomes in patients with atherosclerotic
carotid artery disease (ATH) compared with non-atherosclerotic carotid
artery disease (NON; including restenosis and radiation-induced stenosis).
Methods: VR collects provider-reported data on CAS using a web-
based database. Data were analyzed at the pre-operative, procedure, pre-
discharge, and 30-day intervals.
Results: As of 20/Nov/2008, there were 4,017 CAS patients with
discharge data, of which 72% were due to ATH. Of the NON cohort, 76%
were restenosis, 16% were radiation-induced, and 8% other. Baseline demo-
graphics showed ATH were older (72 yrs vs. 69 yrs, p0.001), more often
male (61% vs. 57%, p0.02) and more Hispanic-origin (5% vs. 3%,
p0.001). Also, ATH had a higher prevalence of pre-procedure CAD, MI,
VHD, CHF, arrhythmia, diabetes, and COPD; whereas NON had a higher
prevalence of pre-procedure TMB/amaurosis fugax, smoking, and cancer.
Clinically significant intra-procedural arrhythmia (1.7% vs. 0.88%, p0.04)
and hypotension (6.8% vs. 1.8%, p0.0001) were greater in ATH; while
NON had more acute occlusion (0.35% vs. 0.03%, p0.03). There were no
statistically significant differences in death/stroke/MI at peri-operative or
30-day time points (Tables 1 & 2). ATH had higher incidence of peri-op
TIA (1.5% vs. 0.6%, p0.02) and close to statistical significance in 30-day
TIA (3.2% vs. 1.7%, p0.052). There were no differences in outcomes when
performing gender analysis either within-group or between-group. Finally,
there was no statistical difference at 30-day outcome when comparing
symptomatic (8.9% ATH vs 7.4% NON, p0.53) and asymptomatic (5.6%
ATH vs. 4.5% NON, p0.43) patients.
Conclusion: While ATH patients appear sicker due to statistically
significant co-morbidities, they did not have statistically significant increased
rates of death/stroke/MI at peri-operative or 30-days when compared with
NON. With continued enrollment and follow-up, analysis of VR will sup-
plement RCTs by providing CAS outcomes in current clinical practice with
sufficient numbers to serve as an outcome assessment tool of important
patient subsets and across the spectrum of peripheral vascular procedures.Author Disclosures: R.A. White, None; G.A. Sicard, None; R.M.
Zwolak, None; A.N. Sidawy, None; M.L. Schermerhorn, None; F.S.
Siami, None.
SS34.
Carotid Stenosis In Women: A Claim For Carotid Stenting?
Paola De Rango, Gianbattista Parlani, Fabio Verzini, Enrico Cieri, Giuseppe
Giordano, Piergiorgio Cao. Vascular and Endovascular Surgery Unit,Uni-
versity of Perugia, Perugia, Italy
Objective:Randomized trials (RCT) of carotid endarterectomy (CEA)
demonstrated little benefit from surgery in women because of high operative
risk. Whether these findings are also applicable to carotid artery stenting
(CAS) remains subject of investigation. Our aim was to determine whether
gender differences exist in the risk of perioperative complications related to
CAS.
Methods: Data from a single-center carotid surgery database, includ-
ing 1087 CAS (312 women; 775 men) and 1109 CEA (319 women;790
men), in unselected population, were analyzed. Perioperative risks of death,
stroke, and local complications in men and women undergoing CAS and
CEA were compared.
Results: The perioperative risks of stroke or death were not statistically
different in CAS women compared to CAS men (2.2% vs 3.1%; odds ratio
[OR]0.3; 95% CI: 0.56-3.1; p0.54) either symptomatic or not. How-
ever, CAS women were more prone to experience minor local complications
(1.6% vs 0.9%) and less likely to have a disabling stroke (0.6% vs 1.4%) or TIA
(2.8% vs 3.2%) and cardiac complication (0% vs 0.4%) with respect to men.
Conversely, in the CEA cohort, the perioperative risk of death and stroke
was, although non statistically, higher in women than in men (2.8% vs 1.4%,
p0.2), and the stroke risk was particularly higher in asymptomatic women
[2.9% vs 0.6%; OR: 4.6, CI: 1.2-23.0, p0.02)]. The risk of stroke or death
in CAS and CEA women were similar (p0.4).
Conclusions: Women and men with carotid stenosis have similar early
favourable outcome from CAS in experienced centers. CAS should not be
discouraged as a primary choice for treatment of carotid stenosis in women.
Results from large RCTs are awaited to prove if CAS, will truly benefit





death in men p
CAS (all patients) 7/312 (2.2%) 24/775 (3.1%) 0.54
CAS for symptomatic 3/65 (4.6%) 9/203 (4.4%) 1
CAS for asymptomatic 4/247 (1.6%) 14/572 (2.4%) 0.6
CEA (all patients) 9/319 (2.8%) 12/790 (1.5%) 0.2
CEA for symptomatic 3/105 (2.9%) 9/308 (2.9%) 1
CEA for
asymptomatic
6/214 (2.8%) 3/482 (0.6%) 0.02
Author Disclosures: P. De Rango, None; G. Parlani, None; F. Verzini,
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Comparative Study on Carotid Revascularization (CEA Versus CAS)
Using Markers of Cellular Brain Injury, Neuropsychometric Tests and
DW-MRI
Laura Capoccia1, Francesco Speziale1, Marianna Gazzetti1, Paola Mariani2,
Annarita Rizzo1, Wassim Mansour1, Paolo Fiorani1. 1Vascular Surgery
Division, Department of Surgery “Paride Stefanini”, Policlinico Umberto I,
Sapienza University of Rome, Rome, Italy; 2Institute of Biological Chemis-
try, Department of Surgery “Paride Stefanini”, Policlinico Umberto I,
Sapienza University of Rome, Rome, Italy
Objective: Subclinical alterations of cerebral function can occur during
or after carotid revascularization and can be predict by simple tests admin-
istration. The aim of this comparative study is to assess the relationship
between serum level of two biochemical markers of cerebral injury and
post-operative DW-MRI and neuropsychometric testing (MMSE test) in
two groups of patients submitted to carotid revascularization for high-grade
stenosis.
Methods: Forty-three consecutive asymptomatic patients underwent
carotid revascularization by endarterectomy (CEA20) or stenting
(CAS23). They were submitted to diffusion-weightedmagnetic resonance
imaging (DW-MRI) and Mini-mental State Examination (MMSE) test
